WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ian MortimerPRESIDENT CEO INTERIM CFO2025-10-0125,000$7.69
$192.25kBuy
Ian MortimerPRESIDENT CEO INTERIM CFO2025-10-0125,000$40.16
$1.00MSell
Steven GannonDirector2025-06-053$30.48
$91.44Sell
Steven GannonDirector2025-05-145,144$12.57
$64.66kBuy
Ian MortimerPRESIDENT CEO2025-01-2715,166$17.76
$269.35kBuy
Ian MortimerPRESIDENT CEO2025-01-2715,166$40.46
$613.62kSell
Ian MortimerPRESIDENT CEO2025-01-271,149$17.76
$20.41kBuy
Ian MortimerPRESIDENT CEO2025-01-271,149$41.07
$47.19kSell
Ian MortimerPRESIDENT CEO2025-01-2422,468$17.76
$399.03kBuy
Ian MortimerPRESIDENT CEO2025-01-2422,468$40.20
$903.21kSell

1 of 3

XENE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.52%8,884,363$374.74MInstitution
Avoro Capital Advisors LLC7.00%5,400,000$227.77MInstitution
Blackrock Inc6.96%5,365,327$226.31MInstitution
Driehaus Capital Management LLC5.62%4,335,648$182.88MInstitution
Braidwell LP4.68%3,605,029$152.06MInstitution
Janus Henderson Group PLC4.64%3,577,735$150.91MInstitution
Capital International Investors4.13%3,181,549$134.20MInstitution
Commodore Capital LP3.92%3,025,000$127.59MInstitution
Polar Capital Holdings PLC3.51%2,703,256$114.02MInstitution
Wellington Management Group LLP2.82%2,174,761$91.73MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE97.09%2.91%Net BuyingNet Buying
CGON84.47%15.53%Net BuyingNet Buying
APGE90.93%9.07%Net SellingNet Selling
CNTA89.96%10.04%Net SellingNet Selling
RARE85.46%14.54%Net SellingNet Selling
View Top Biotech Stocks

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 107.81% institutional shareholders, 3.23% Xenon Pharmaceuticals insiders, and 0.00% retail investors. Evan A. Stein is the largest individual Xenon Pharmaceuticals shareholder, owning 1.04M shares representing 1.35% of the company. Evan A. Stein's Xenon Pharmaceuticals shares are currently valued at $43.02M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.